Due to the severe overseas epidemic, the global demand for covid-19 virus detection kit has surged. In the United States, the price of two dose quick screening kits is usually $14 ~ 24. Now, due to the shortage of supply, the price has doubled to $75 (about 478.2 yuan) in some markets, and even $80 (about 510.1 yuan).
With the continuous warming of overseas epidemic, war epidemic enterprises forgotten and even abandoned by the capital market have once again attracted the attention of investors.
In the past two years of global anti epidemic, Chinese enterprises have continuously provided all kinds of war epidemic materials, including masks, detection reagents, infrared detectors, medical equipment and so on, making important contributions to the global anti epidemic.
Taking covid-19 test reagent as an example, according to the statistics of China Medical Insurance chamber of Commerce, by the end of 2020, more than 500 enterprises had included covid-19 test reagent in the export white list. According to the data of China Customs, in 2020, 1.08 billion covid-19 testing reagents will be exported, and the sales revenue of covid-19 reagents is expected to be about US $5 billion. According to the Research Report of BCC research, the global covid-19 testing market is expected to reach US $60.3 billion in 2020, US $84.4 billion in 2021 and US $195.1 billion in 2027, with an average annual compound growth rate of 15%.
Although there are hundreds of enterprises with export white list, in fact, after nearly two years of fierce market competition, the export of China’s covid-19 testing reagent shows a trend of focusing on advantageous enterprises.
According to the customs data, in the first 11 months of 2021, the export of covid-19 reagent peaked from April to 5, and decreased significantly from July to September. However, in October and November, with the resurgence of the overseas epidemic, the national export of covid-19 reagent gradually picked up.
The data also shows that during the export peak period from April to may 2021, the export volume of Zhejiang, Fujian and Beijing occupies the top three, and the export volume of the three places is basically the same, with little difference. In the second half of 2021, the export of testing reagents will quickly concentrate on Zhejiang enterprises. For example, in November 2021, the export volume of Zhejiang is almost four times that of Beijing and Fujian.
Behind the changes in the export data of the above three provinces are mainly the significant increase in exports of Zhejiang Orient Gene Biotech Co.Ltd(688298) , Hangzhou Alltest Biotech Co.Ltd(688606) and Asahi biology, of which Zhejiang Orient Gene Biotech Co.Ltd(688298) contributed the most. The company received a large number of orders from the United States and the European Union last year. On the other hand, the orders of testing reagent enterprises in other provinces and cities were crowded out and even eliminated.
(source: Securities Times)
